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ABSTRACT
Objectives: To evaluate 3 pilot chlamydia retesting
programmes in South West England which were
initiated prior to the release of new National Chlamydia
Screening Programme (NCSP) guidelines
recommending retesting in 2014.
Methods: Individuals testing positive between August
2012 and July 2013 in Bristol (n=346), Cornwall
(n=252) and Dorset (n=180) programmes were eligible
for inclusion in the retesting pilots. The primary
outcomes were retest within 6 months (yes/no) and
repeat diagnosis at retest (yes/no), adjusted for area,
age and gender.
Results: Overall 303/778 (39.0%) of participants were
retested within 6 months and 31/299 (10.4%) were
positive at retest. Females were more likely to retest
than males and Dorset had higher retesting rates than
the other areas.
Conclusions: More than a third of those eligible were
retested within the time frame of the study. Chlamydia
retesting programmes appear feasible within the
context of current programmes to identify individuals
at continued risk of infection with relatively low
resource and time input.
INTRODUCTION
Chlamydia is the most commonly diagnosed
bacterial sexually transmitted infection (STI)
in the UK. In England, the National
Chlamydia Screening Programme (NCSP)
was piloted in 2003 and implemented nation-
ally in 2008.1 The NCSP recommends that
sexually active young men and women aged
<25 years are tested for chlamydia annually
and on change of sexual partner. In 2013, in
England, over 1.7 million chlamydia tests
were performed, equating to 25% coverage
in 15–24-year.olds. Nationally 14 000 diagno-
ses of chlamydia were made, positivity 8.1%.
Women are tested more than men, with 69%
of tests occurring in women.2 Case manage-
ment of positives includes: antibiotic
treatment, partner notiﬁcation support and
provision of safer sex advice. In August 2013,
the English NCSP recommended routine
offer of a retest for all chlamydia-positive
adults after 3 months.3 Prior to this, there
was no speciﬁc recommendation regarding
retesting, although individuals would be
offered tests opportunistically at any attend-
ance and are free to seek testing at any time.
Individuals who test positive for chlamydia
are at an increased risk of subsequently
testing positive compared with those who ini-
tially test negative.4 Repeat infections are
associated with an increased risk of pelvic
inﬂammatory disease and other long-term
reproductive sequelae.5
The most effective or cost-effective way to
deliver a chlamydia retesting programme
within the NCSP context is not known, and
local areas need to determine how best to
implement the new guidelines within their
local system.1 A recent systematic review of
active recall for STI and HIV testing found
that active recall increased reattendance or
retesting in 13 of 14 studies.6 Home sam-
pling and SMS reminders appeared to
increase retesting, but the range was wide
and the evidence limited by study
Strengths and limitations of this study
▪ This study reflects the experience of local areas
in implementing new guidance on retesting for
chlamydia within the context of the existing
National Chlamydia Screening Programme.
▪ Delivering retesting appears feasible and is likely
to diagnose reasonable numbers of additional
infections (10% of those retested within the pilot
were infected).
▪ The study is limited mainly because the interven-
tions were not standardised across the study
sites.
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heterogeneity.6 An earlier study in Cornwall showed that
individuals testing positive were more than twice as likely
to retest positive than those testing negative (19.4% vs
7.2%).7 In 2012, following the NCSP workshop and con-
sultation about a change in recommendations, pilot
retesting programmes were implemented in three areas;
Bristol (Avon), Cornwall and Dorset. (Note: Avon refers
to the Bristol chlamydia screening ofﬁce, which covered
the Avon area of Bristol, North Somerset, South
Gloucestershire and Bath and North East Somerset
(BANES) as in previous Primary Care Trust (PCT)
organisational structure.) In this study we present an
evaluation of these three retest pilot programmes to
assess what retest rates and positivity can realistically be
expected when retesting is implemented nationally.
METHODS
Study population: All individuals who tested positive for
chlamydia at their initial visit were eligible for inclusion.
Settings: All three sites are located in South West
England. The Bristol site included Bristol city and the
surrounding area (Avon). Bristol city is a large, urban
centre, with large black ethnic minority population and
signiﬁcant areas of high deprivation and has the highest
test volume and population. The surrounding area is
rural/suburban. Dorset is a rural, afﬂuent county includ-
ing the county town of Dorchester. Cornwall is a large,
rural county on the South Western peninsula of
England. Chlamydia tests in all areas are offered by a
variety of service providers with different models of
access: genitourinary medicine clinics (GUM), sexual
and reproductive health clinics, family planning services,
general practice (GP), pharmacies and young peoples’
services such as Brook clinics all offer chlamydia testing.
We chose these areas to broadly reﬂect the range of
practice nationally. The delivery of NCSP is locally
devolved, and so organisation of chlamydia screening
nationally is very heterogeneous and reﬂects local dem-
ography, geography and population needs as well as his-
torical organisation of services.
Each area determined locally how to conduct the pilot
to ﬁt with their current organisation of screening and
patient management (illustrated in ﬁgure 1), therefore
did not require consistency of scripting in phone calls or
text message content. Furthermore, some areas modi-
ﬁed their approach in response to user feedback or
their experiences. While this reduces the comparability
and reproducibility of these pilots, we nonetheless feel it
is important to report the experience and outcomes that
were achieved in a ‘real-life’ implementation setting.
Outcomes: Number retested within 6 months and more
than 2 weeks after primary test (yes/no) and number
reinfected at retest (yes/no). Outcomes were adjusted
for age (15–19, 20–25), gender and area of study
(Bristol, Dorset, Cornwall).
Figure 1 Resting pathway followed in each area (GP, general practice; GUM, genitourinary medicine clinics).
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Study design
In each area, individuals were contacted routinely
2 weeks after their initial visit either to check compli-
ance with their treatment (Bristol and Cornwall) or to
discuss their result (Dorset). During this encounter,
individuals were informed about their risk of retesting
positive and recommended to retest (ﬁgure 1). In
Bristol and Cornwall, this compliance check was via tele-
phone, and in Dorset, they were either contacted by
telephone or seen in clinic to discuss results. In Bristol
and Cornwall, the pilots were run by the chlamydia
screening ofﬁce, whereas in Dorset, it was run by the
genitourinary (GUM) clinic. Data were collected on age,
gender, date of treatment, date and result of retest,
whether a postal kit was sent and returned and number
of contact attempts. Postal kits contained full instruc-
tions to collect urine or vaginal swab and contained a
freepost return envelope to return tests to the
laboratory.
In Cornwall, individuals were asked for consent to be
contacted and recalled in 5 months. If they gave consent
a note was made in their records, and up to eight
attempts to contact were made (2 calls every week for
4 weeks with a voicemail or SMS, depending on patient
preference). If contact was made (patient answered or
called back), they were offered a choice of postal testing
kit or advised to attend GUM clinic or GP. Individuals
were followed up to see if a retest was undertaken and a
record of any retests, the result and the venue was made.
Individuals who did not wish to be contacted or who
could not be contacted remained eligible for the study
since they were advised to retest at 3 months, but did
not receive a reminder. In Bristol and Dorset, individuals
were simply asked if they would prefer to be sent a
postal kit or an SMS reminder at 12 weeks. No discussion
around consent to be recalled occurred in Bristol or
Dorset. In Bristol and Dorset, those that opted for a
postal kit were sent it at 12 weeks, which was also accom-
panied by an SMS reminder in Bristol. Those who did
not want to be sent a postal kit were just sent an SMS
reminder either to contact the screening ofﬁce or make
an appointment at the GUM clinic. Only one SMS
reminder was sent in Bristol and Dorset (compared with
multiple attempts in Cornwall). For each individual, it
was recorded if a postal kit was sent and whether it was
returned, whether they retested via an alternative route
(with details if known) and what the results of any
retests were.
Each area provided a data set of individuals testing
positive during 6–8 months between August 2012 and
Table 1 Summary of retesting study participants (age, gender and area): with number and percentage retested and
rediagnosed in Cornwall, Bristol and Dorset, England, August 2012–July 2013
Area Gender Age N N retested
Percentage
retested
Confirmed
result Positive
Percentage
positive
Bristol Female 15–19 79 32 40.5 31 4 12.9
20–25 167 74 44.3 73 7 9.6
Subtotal (gender) 246 106 43.1 104 11 10.6%
Male 15–19 14 2 14.3 2 0 0.0
20–25 86 22 25.6 20 2 10.0
Subtotal (gender) 100 24 24.0 22 2 9.1
Subtotal (area) 346 130 37.6 126 13 10.3
Cornwall Female 15–19 53 24 45.3 24 1 4.2
20–25 142 60 42.3 60 9 15.0
Subtotal (gender) 195 84 43.1 84 10 11.9
Male 15–19 7 1 14.3 1 0 0.0
20–25 50 7 14.0 7 1 14.3
Subtotal (gender) 57 8 14.0 8 1 12.5
Subtotal (area) 252 92 36.5 92 11 12.0
Dorset Female 15–19 37 24 64.9 24 2 8.3
20–25 57 29 50.9 29 2 6.9
Subtotal (gender) 94 53 56.4 53 4 7.5
Male 15–19 23 7 30.4 7 1 14.3
20–25 63 21 33.3 21 2 9.5
Subtotal (gender) 86 28 32.6 28 3 10.7
Subtotal (area) 180 81 45.0 81 7 8.6
Total Female 15–19 169 80 47.3 79 7 8.9
20–25 366 163 44.5 162 18 11.1
Subtotal (gender) 535 243 45.4 241 25 10.4
Male 15–19 44 10 22.7 10 1 10.0
20–25 199 50 25.1 48 5 10.4
Subtotal (gender) 243 60 24.7 58 6 10.3
778 303 38.9 299 31 10.4
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July 2013 who were then followed up for a further
6 months to assess whether they were retested and the
result of the retest. The raw data from each area were
standardised and collated in an Excel spreadsheet (pro-
vided as pdf in online supplementary material,
Supplementary_individual_level_data.pdf). Patient iden-
tiﬁable data (name, date of birth or postcode) were
removed and each individual was given a study ID prior
to analysis. Individuals were excluded from the analysis
if they were older than 25 years of age or younger than
15 or if the information collected was incomplete.
For Cornwall analyses of retesting rates according to
(1) the number of attempts to contact individuals and
(2) whether or not consent to be recalled was given,
were also conducted.
We used logistic regression to analyse the primary out-
comes of retesting and positivity at retest. This was done
in STATAV.13.1 StatCorp. We describe the retesting path-
ways in online supplementary appendix 1. No ethical
approval was sought as this was a modiﬁcation of current
practice and data were anonymised.
In order to provide a benchmark for self-selected
retesting in the absence of a speciﬁc retest guideline, we
looked back at data previously collected in Cornwall.4
For those tested during the ﬁrst half of 2008 ( January–
June), we calculated the number who were retested
within 6 months and the proportion positive and nega-
tive at ﬁrst and second test. Comparable data were not
available for Dorset or Bristol.
RESULTS
During the study period (August 2012–July 2013), data
were collected on 862 individuals testing positive for
chlamydia.
Data cleaning
Individuals were excluded if aged under 15 years, over
25 years or if records were incomplete. Cornwall: there
were no exclusions giving 252 records included.
Bristol: out of 377 records eligible for inclusion, 5
were excluded as patient/outcome details incomplete
Table 2 Logistic regression of retesting probability, with unadjusted and adjusted ORs (by area of study, gender and age
group)
Unadjusted Adjusted
N (778)
Retested
(243)
Percentage
retested OR
CI
p Value OR
CI
p Value
Lower
95%
Upper
95%
Lower
95%
Upper
95%
Area
Bristol 346 130 38 Ref Ref
Cornwall 252 92 37 0.96 0.68 1.34 0.79 0.9 0.64 1.26 0.534
Dorset 180 81 45 1.36 0.94 1.96 0.1 1.69 1.15 2.49 0.008
Gender
Male 243 60 25 Ref Ref
Female 535 243 45 2.5 1.81 3.56 <0.001 2.87 2.01 4.1 <0.001
Age
15–19 213 90 42 Ref Ref
20–25 565 213 38 0.83 0.6 1.14 0.246 0.99 0.71 1.38 0.95
Table 3 Logistic regression of positivity at retest, with unadjusted and adjusted ORs (by area of study, gender and age
group) for those with a confirmed negative or positive result at retest
Unadjusted Adjusted
Retest
(299)
Retest
positive (31)
Percentage
positive OR
95% CI
p Value OR
95% CI
p ValueLower Upper Lower Upper
Area
Bristol 113 13 11.5 Ref
Cornwall 81 11 13.6 1.18 0.5 2.77 0.703 1.19 0.5 2.8 0.693
Dorset 74 7 9.5 0.82 0.31 2.12 0.691 0.83 0.31 2.23 0.716
Gender
Male 52 6 11.5 Ref
Female 216 25 11.6 1 0.39 2.57 0.995 0.95 0.35 2.54 0.915
Age
15–19 81 8 9.9 Ref
20–25 187 23 12.3 1.25 0.53 2.9 0.611 1.21 0.51 2.86 0.669
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and 26 excluded as over 25 years old leaving 346
records included. Dorset: out of 243 records eligible
for inclusion, 5 were excluded as details incomplete, 1
excluded as <15 years old and 57 were excluded as
over 25 years old leaving 180 records included. This
gave a total of 778 records of individuals diagnosed
with chlamydia eligible for inclusion in the study
across the three areas (Bristol 346, Cornwall 252,
Dorset 180). The results are summarised in table 1.
Most participants were female (68.8%) with a mean
age of 21 years.
Overall, 39% (303/778) of individuals were retested
within 6 months of their original chlamydia diagnosis. In
the pilot areas 779 positives were eligible for retesting, of
whom 303 were retested and 31 were positive. In the
context of the South of England where positivity is 7.5%,
this equates to over 10 000 tests performed to generate
303 retests.
The results of logistic regression to calculate the OR
for retesting are given in table 2, presented as
unadjusted and adjusted values; adjusted for area of
study, age group (15–19, 20–25) and gender. The
outcome was retest between 2 weeks and 6 months (yes/
no) of the primary test. In the unadjusted analysis, only
female gender was signiﬁcantly associated with increased
odds of retesting (OR 2.54, 95% CI 1.81 to 3.56). In the
adjusted analysis, female gender (OR 2.87, 95% CI 2.01
to 4.10) and being tested in Dorset (OR 1.69, 95% CI
1.15 to 2.49) were signiﬁcantly associated with higher
levels of retesting.
Among those retested with a conﬁrmed negative or
positive result, the positivity of chlamydia was 10.4%
(31/299). In logistic regression, there was no signiﬁcant
difference in retest positive by area, age or gender,
shown in table 3.
Postal kit use varied substantially (Dorset 0%,
Cornwall 27% and Bristol 85%), and return rates also
varied (Cornwall 28/42 (67%), Bristol 98/295 (33%),
kits were returned (includes one which had not been
sent out by the team)). Bristol offered postal kits as
default, Cornwall offered a choice when retesting was
offered and Dorset did not offer postal kits, therefore
only Cornwall likely reﬂects patient choice per se.
Additional descriptive analysis of Cornwall experience
Cornwall collected more comprehensive data than the
other sites and also undertook more extensive efforts to
contact patients for retesting. We had also previously
analysed data on reinfection and retesting in Cornwall
prior to this study, so were able to re-extract comparable
data on retesting prior to the updated guidelines.
In Cornwall, 47.5% (58/122) of those who consented
to be recalled, and 26.2% (34/130) of those who did
not consent were retested (table 4). Women were more
likely to consent than men, but there was no difference
by age. In logistic regression, those who consented to be
contacted were more than twice as likely to be retested
after adjustment for age and gender (OR 2.27, 95% CI
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1.32 to 3.91). Conversely those who did consent were
less likely to be infected at retest compared with those
who did not consent to be contacted (OR 0.16, 95% CI
0.03 to 0.73). Full details are provided in online supple-
mentary table A1.
Up to eight attempts to contact individuals about
retesting were made in Cornwall, but multiple contact
attempts (more than 3) did not result in higher retest
rates. If patients were not contacted in three attempts,
they were unlikely to be contacted at all: only 5/81
patients who were contacted more than three times were
successfully contacted.
We reanalysed data collected previously in Cornwall to
calculate a comparable retest rate before the pilot was
implemented, that is, in the absence of a speciﬁc recom-
mendation to retest within 6 months. In Cornwall, there
were 9489 individuals tested between January and June
2008, of whom 613 (6.46%) were positive. The results of
the subsequent tests according to the result of the ﬁrst
test are given in table 2. Overall, 12.6% (77/613) of
those positive were retested in the interval on or after
2 weeks and less than 6 months after the initial test. For
individuals who were positive at the initial test and who
were retested, 9.1% (7/77) were positive again at the
subsequent test (tables 4 and 5).
DISCUSSION
Over a third (39%) of chlamydia-positive individuals
were retested following the introduction of three differ-
ent retesting pilots. Women were more than twice as
likely as men to be retested and Dorset achieved higher
retest rates than other areas (signiﬁcant only in the
adjusted logistic regression; Bristol (38%), Cornwall
(37%), Dorset (45%)). These rates were obtained in the
context of normal clinical practice rather than a rando-
mised control trial, and therefore we suggest that retest-
ing rates of 40% are achievable in most areas.
The chlamydia positivity among those retested was
10.4%, which is higher than the overall positivity rate for
the south of England in 2012 (7.5%).1 Individuals found
to be positive at retest may beneﬁt from additional
health promotion and assistance with partner notiﬁca-
tion. Compared with the previous Cornwall study, the
proportion reinfected at retest was similar (10.2% in
2012/13 compared with 9.1% found in our reanalysis of
data from 2008).7 The proportion retested with an active
recall approach (39%, 304/779) was much higher in the
pilot areas than in Cornwall (13%, 77/613) when there
was no speciﬁc guideline to retest.
In Cornwall, considerable effort was invested in both
obtaining consent and contacting clients, but this did
not signiﬁcantly increase the retesting rate in compari-
son to the Bristol and Dorset pilots. Multiple contacts
are therefore unlikely to be a cost-effective use of
resources. Similarly, postal kits were preferred by some
individuals but resulted in high wastage from non-return
of kits, particularly in Bristol where these were the
primary method of retesting. Notably, a quarter of those
who did not consent to be reminded were retested in
Cornwall, and were more likely to be infected than
those who had consented to be contacted. This may
indicate that individuals are able to accurately assess
their risk and seek chlamydia screening actively and
appropriately. However, of those who received the inter-
vention (reminders and postal kits), the retesting rates
increased to 48%, suggesting that for many people add-
itional strategies are needed.
In this evaluation, retesting rates were fairly high
across the three areas compared with rates found in
studies conducted in the USA and Australia.8 9
Moderate levels of chlamydia retesting have been
reported in England, in the absence of a speciﬁc recom-
mendation.10 A systematic review found that reminders
and postal screening kits could increase retesting rates
by 80% and 25%, respectively.11 Recently Desai et al6
also found that home sampling and SMS reminders
appeared to increase retesting, but the range was wide
and the evidence limited by study heterogeneity. Studies
in Australia indicated that SMS reminders increased
retesting rates and that an additional ﬁnancial incentive
did not increase rates further.9
The study is limited because the interventions were
not standardised and there was no control group. There
was variability in the time frame and approach to offer-
ing retesting across the areas. Bristol predominantly
offered a postal test at 12 weeks, Dorset arranged a clinic
appointment at 12 weeks and Cornwall offered retest by
post or clinic appointment at 5 months (20 weeks).
Reporting also lacked robustness as individuals could
have retested elsewhere (eg, through pharmacy or
online testing). No information was available on sexual
behaviour since ﬁrst positive or on partner management
of individuals retested. The use of postal kits was highly
variable, either offered as default (Bristol), an option
(Cornwall) or not offered (Dorset). Return rates of kits
Table 5 Retesting prior to implementation of routine retest recommendation in Cornwall7
Test 1 Negative (n=8876) Positive (n=613) Total (n=9489)
Number retested Test 2 negative 638 70 708
Test 2 positive 36 (5.3%) 7 (9.1%) 43 (5.7%)
Total 674 77 751
Proportion retested 674/8876 (7.6%) 77/613 (12.6%) 751/9489 (7.9%)
Reanalysis of previously published data from Cornwall on reinfection and retesting in 2008–2009.
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were somewhat higher when they had been chosen by
patients in Cornwall than offered routinely in Bristol. We
removed post code information to preserve anonymity,
but these data may be useful in assessing whether dis-
tance from clinic predicts preference for postal testing.
The ﬁndings may not be directly applicable to other
settings, since all areas organise chlamydia screening
activities differently. However, we believe the similarities
in retesting and positivity at retest, despite differences
and inconsistencies in implementation through the
study, outweigh the differences and indicate that 40%
retest rate is a reasonable level to achieve in practice,
alongside continued recommendation to test annually
and on change of partner.
The change in guidelines was implemented locally to
ﬁt with local screening arrangements which is both a
strength in that it provides ‘real-life’ insight, but also a
weakness since the areas did not all implement retesting
in exactly the same way. Other areas in England can
learn from our experiences and ensure that current
levels of retesting are audited, and that a robust protocol
for undertaking and evaluating retesting is implemented
prior to local changes in practice. Chlamydia retesting
programmes appear feasible within the context of
current programmes to identify individuals at continued
risk of infection with relatively low resource and time
input.
Implications for local practice
Based on the ﬁndings and experience from our collea-
gues providing chlamydia retesting within the NCSP, we
recommend that clinics ensure that robust data systems
should be in place to enable auditing of retest. Clinics
should offer patient choice for retesting method, use
automated SMS messaging where possible, consider gen-
erating clinic appointments (with SMS reminders a few
days in advance). No more than three attempts to
contact an individual should be made.
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